Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
After an IRA rollover, selecting the right index fund matters for long-term growth and risk management. Compare options and choose confidently.
26,327 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
New data covering about 88 million employees shows worker engagement at a decade-low, with managerial practices ident...
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...
The Federal Reserve’s 2026 annual stress test finds the largest U.S. banks would weather a sharp downturn without fai...
A rapid attribution study links this summer’s extreme European heat to human-caused climate change, showing europe wa...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Bridgewater Associates pivots its recruiting to emphasize resilience, drawing on Ray Dalio’s own history as a ‘terrib...
Wells Fargo analysts expect a constructive stretch for U.S. equities into the warmer months, provided volatility stay...
Cleveland Fed President Beth Hammack signals a hawkish tilt, arguing inflation and a tight labor market could justify...
Analysts warn that the CLARITY Act's odds of passing have fallen below 50% as the Senate's August recess approaches. ...
President Trump disclosed a $2.2 billion 2025 income, including roughly $1 billion from crypto. Washington’s ethics e...
Meta's exploration of renting idle GPU capacity as a cloud resource has sparked a heated, split view on Wall Street. ...